| News

Roche Coronavirus test gets FDA approval

16.03.2020

The US regulatory authority has authorized a test developed by the Basel-based pharmaceutical company Roche to detect the SARS-CoV 2 virus. Due to Roche’s work, numerous additional tests can be carried out in the USA, and for this reason Roche received the express thanks of President Trump.

Roche logo on building (Img: Roche)

The Food and Drug Administration (FDA) has authorized the cobas SARS-CoV-2 test developed by Roche on an emergency use basis, as detailed in a press release issued by the Basel-based pharmaceutical company. The coronavirus test will therefore be available in all markets that accept the CE mark.

The Roche test will allow the number of tests to check whether a person has been infected with the coronavirus in the USA to be significantly increased. In remarks made by Donald Trump, the US President commented: “I want to thank Roche, a great company, for their incredible work”. This will allow an additional 1.4 million tests to be carried out in the near future, with an additional 5 million tests even possible within a month, Trump explained. In addition to praising Roche, the President also expressed thanks to Thermo Fisher.

In order to carry out the coronavirus tests developed by Roche, hospitals and laboratories require either of the cobas 6800 or cobas 8800 automated systems. These are widespread in the USA and around the world, according to Roche. The comprehensive testing capacities that are now available will allow rapid, effective reactions to combat this pandemic, explains Thomas Schinecker, CEO of Roche Diagnostics, in the press release. With cobas 6800/8800, a total of 96 tests can be analyzed within the space of three hours. Extra test stations increase this number further still. With cobas SARS-CoV-2, the results of the coronavirus tests are available within three-and-a-half hours, Roche states.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Bottmedical enters the market with innovative braces
Basel Area Business & Innovation, Innovation, Invest

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

Read More
TargImmune raises nearly 18 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

TargImmune raises nearly 18 million Swiss francs

The Basel-based biotechnology firm TargImmune has raised 17.7 million Swiss francs as part of a financing round. It now intends...

Read More
KetoSwiss launches first product in the USA
Basel Area Business & Innovation, Innovation, Invest

KetoSwiss launches first product in the USA

The Basel-based biotech startup KetoSwiss develops innovative therapies for neurological disorders. Following a successful capital increase, the company now has...

Read More
For Swiss startups, China might be closer than it seems
Basel Area Business & Innovation, Invest

For Swiss startups, China might be closer than it seems

China wants to strengthen domestic demand and be less dependent on imports. This policy has huge implications for the life...

Read More
Basel Area treads unique path
Basel Area Business & Innovation, Innovation, Invest

Basel Area treads unique path

Basel Area is responsible for both location and innovation promotion. This approach, which is unique across Switzerland, is very successful...

Read More
Alentis secures 67 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Alentis secures 67 million US dollars

The Basel-based biotechnology company Alentis Therapeutics has secured 67 million US dollars in a series B funding round. The funds...

Read More
RocketVax secures partners for coronavirus vaccine in Basel
Basel Area Business & Innovation, Innovation

RocketVax secures partners for coronavirus vaccine in Basel

RocketVax has found cooperation partners for the development of its innovative coronavirus vaccine. The University Hospital of Basel, the University...

Read More
Bright Peak secures investment of 107 million dollars
Basel Area Business & Innovation, Innovation, Invest

Bright Peak secures investment of 107 million dollars

Bright Peak has raised a total of 107 million US dollars as part of a financing round. The biotechnology firm...

Read More
LCB lands major contract
Basel Area Business & Innovation, Innovation, Invest

LCB lands major contract

LCB Sàrl is active in the areas of Human Machine Interface as well as software and electronics development. The company...

Read More
1 2 3 28

Do you have a question? We'd like to hear from you.